CoChat

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Open access
Li, Kai, Lin, Yusheng, Luo, Yichen, Xiong, Xiao, Wang, Lu, Durante, Kameron, Li, Junkuo, Zhou, Fuyou, Guo, Yi, Chen, Shaobin, Chen, Yuping, Zhang, Dianzheng, Yeung, Sai-Ching Jim, Zhang, Hao · 2022 · Molecular Cancer
Cited by 183

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: The tRNA-derived small RNAs (tsRNAs) are produced in a nuclease-dependent manner in responses to variety of stresses that are common in cancers. We focus on a cancer-enriched tsRNA signature to develop a salivary exosome-based non-invasive biomarker for human esophageal squamous cell carcinoma (ESCC). Methods: Cancer-enriched small RNAs were identified by RNA sequencing of salivary exosomes obtained from ESCC patients (n = 3) and healthy controls (n = 3) in a pilot study and further validated in discovery cohort (n = 66). A multicenter prospective observational study was conducted in two ESCC high-incidence regions (n = 320 and 200, respectively) using the newly developed biomarker signature. Results: The tsRNA (tRNA-GlyGCC-5) and a previously undocumented small RNA were specifically enriched in salivary exosomes of ESCC patients, ESCC tissues and ESCC cells. The bi-signature composed of these small RNAs was able to discriminate ESCC patients from the controls with high sensitivity (90.50%) and specificity (94.20%). Based on the bi-signature Risk Score for Prognosis (RSP), patients with high-RSP have both shorter overall survival (OS) (HR 4.95, 95%CI 2.90–8.46) and progression-free survival (PFS) (HR 3.69, 95%CI 2.24–6.10) than those with low-RSP. In addition, adjuvant therapy improved OS (HR 0.47, 95%CI 0.29–0.77) and PFS (HR 0.36, 95%CI 0.21–0.62) only for patients with high but not low RSP. These findings are consistent in both training and validation cohort. Conclusions: The tsRNA-based signature not only has the potential for diagnosis and prognosis but also may serve as a pre-operative biomarker to select patients who would benefit from adjuvant therapy. Trial registration: A prospective study of diagnosis biomarkers of esophageal squamous cell carcinoma, ChiCTR2000031507. Registered 3 April 2016 - Retrospectively registered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-022-01499-8

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 42

  1. Pennathur A, Gibson MK, Jobe BA, et al. Esophageal carcinoma. Lancet. 2013;381(9864):400–12. · DOI · Paper page
  2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52. · DOI · Paper page
  3. Du L, Wang L, Gan J, et al. MTA3 represses Cancer Stemness by targeting the SOX2OT/SOX2 Axis. iScience. 2019;22:353–68. · DOI
  4. Pouliquen X, Levard H, Hay JM, et al. 5-fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French associations for surgical research. Ann Surg. 1996;223(2):127–33. · doi:10.1097/00000658-199602000-00003
  5. Ando N, Iizuka T, Kakegawa T, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan clinical oncology group study. J Thorac Cardiovasc Surg. 1997;114(2):205–9. · DOI
  6. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol. 2003;21(24):4592–6. · DOI · Paper page
  7. Vaidyanathan R, Soon RH, Zhang P, et al. Cancer diagnosis: from tumor to liquid biopsy and beyond. Lab Chip. 2018;19(1):11–34.
  8. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–90. · DOI · Paper page
  9. De Rubis G, Rajeev Krishnan S, Bebawy M. Liquid biopsies in Cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci. 2019;40(3):172–86. · DOI · Paper page
  10. Sharma S, Zhuang R, Long M, et al. Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018;36(4):1063–78. · DOI · Paper page
  11. Li F, Kaczor-Urbanowicz KE, Sun J, et al. Characterization of human salivary extracellular RNA by next-generation sequencing. Clin Chem. 2018;64(7):1085–95. · DOI
  12. Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012;40(21):10937–49. · DOI · Paper page
  13. Jia S, Zhang Q, Wang Y, et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate. EBioMedicine. 2021;65:103253.
  14. Zhu L, Li J, Gong Y, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019;18(1):74. · DOI · Paper page
  15. LeBleu VS, Kalluri R. Exosomes as a multicomponent biomarker platform in Cancer. Trends Cancer. 2020;6(9):767–74. · DOI · Paper page
  16. Cole C, Sobala A, Lu C, et al. Filtering of deep sequencing data reveals the existence of abundant dicer-dependent small RNAs derived from tRNAs. RNA. 2009;15(12):2147–60. · DOI · Paper page
  17. Yamasaki S, Ivanov P, Hu GF, et al. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol. 2009;185(1):35–42. · DOI · Paper page
  18. Thompson DM, Lu C, Green PJ, et al. tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA. 2008;14(10):2095–103. · DOI · Paper page
  19. Thompson DM, Parker R. Stressing out over tRNA cleavage. Cell. 2009;138(2):215–9. · DOI · Paper page
  20. Ivanov P, Emara MM, Villen J, et al. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43(4):613–23. · DOI · Paper page
  21. Couvillion MT, Bounova G, Purdom E, et al. A Tetrahymena Piwi bound to mature tRNA 3′ fragments activates the exonuclease Xrn2 for RNA processing in the nucleus. Mol Cell. 2012;48(4):509–20. · DOI · Paper page
  22. Zong T, Yang Y, Zhao H, et al. tsRNAs: novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif. 2021;54(3):e12977. · DOI
  23. Lin Y, Dong H, Deng W, et al. Evaluation of salivary Exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin Cancer Res. 2019;25(10):3035–45. · DOI
  24. Yu J, Lin Y, Xiong X, et al. Detection of Exosomal PD-L1 RNA in saliva of patients with periodontitis. Front Genet. 2019;10:202. · DOI
  25. Ke X, Xiong X, Lin Y, et al. Chimeric RNA and Exosomes-based liquid biopsy. Methods Mol Biol. 2020;2079:211–8. · DOI
  26. Chan AC, Fan ST, Poon RT, et al. Evaluation of the seventh edition of the American joint committee on Cancer tumor-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system. HPB (Oxford). 2013;15(6):439–48. · DOI
  27. Wang S, Lin Y, Xiong X, et al. Low-dose metformin reprograms the tumor immune microenvironment in human esophageal Cancer: results of a phase II clinical trial. Clin Cancer Res. 2020;26(18):4921–32. · DOI · Paper page
  28. Xiong X, Ke X, Wang L, et al. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target. Proc Natl Acad Sci U S A. 2020;117(12):6726–32. · DOI
  29. Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–95. · DOI · Paper page
  30. Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116(23):e118–27. · DOI · Paper page
  31. Fang S, He T, Jiang J, et al. Osteogenic effect of tsRNA-10277-loaded exosome derived from bone Mesenchymal stem cells on steroid-induced osteonecrosis of the femoral head. Drug Des Devel Ther. 2020;14:4579–91. · DOI
  32. Meng L, Jiang L, Chen J, et al. Transfer RNA-derived fragment tRF-28-QSZ34KRQ590K in plasma exosomes may be a potential biomarker for atopic dermatitis in pediatric patients. Exp Ther Med. 2021;21(5):489. · DOI
  33. Wang J, Ma G, Li M, et al. Plasma tRNA fragments derived from 5′ ends as novel diagnostic biomarkers for early-stage breast Cancer. Mol Ther Nucleic Acids. 2020;21:954–64. · DOI
  34. Wang W, He X, Zheng Z, et al. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Mol Cancer. 2017;16(1):75. · DOI
  35. Zheng X, Xing S, Liu XM, et al. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer. 2014;14:490. · doi:10.1186/1471-2407-14-490
  36. Wang W, Chen D, Zhao Y, et al. Characterization of LAG-3, CTLA-4, and CD8(+) TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma. Ann Transl Med. 2019;7(23):776. · DOI
  37. Cui Y, Chen H, Xi R, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020;30(10):902–13. · DOI · Paper page
  38. Al Kawas S, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol. 2012;57(1):1–9. · DOI
  39. Wong DT. Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn. 2006;6(3):267–72. · DOI
  40. Ogawa Y, Taketomi Y, Murakami M, et al. Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing. Biol Pharm Bull. 2013;36(1):66–75. · DOI · Paper page
  41. Chang SL, Lee SW, Yang SF, et al. Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma. APMIS. 2020;128(4):287–97. · DOI
  42. Li P, Lin Y, Zhang Y, et al. SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med. 2013;11:52. · DOI

Cited by

See all 183

Metadata

Authors
Li, K., Lin, Y., Luo, Y., Xiong, X., Wang, L., Durante, K., Li, J., Zhou, F., Guo, Y., Chen, S., Chen, Y., Zhang, D., Yeung, S.-C. J., & Zhang, H.
Venue
Molecular Cancer
Published
2022-01-18
Volume
21
Issue
1
Pages
21-21
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4205681991
Cited by
183
References
4
FWCI
11.67
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • National Natural Science Foundation of China (82072683, 81773087, 81071736, 81572876, 30973508)
  • Natural Science Foundation of Guangdong Province (2021A1515012522, 9151018004000000)
  • Science and Technology Planning Project of Guangdong Province (2019A030317024)
  • Special Project on the Integration of Industry, Education and Research of Guangdong Province (2011A090100024)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. https://app.cochat.ai/papers/10.1186/s12943-022-01499-8
The paper
Li, K., Lin, Y., Luo, Y., Xiong, X., Wang, L., Durante, K., Li, J., Zhou, F., Guo, Y., Chen, S., Chen, Y., Zhang, D., Yeung, S.-C. J., & Zhang, H. (2022). A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Molecular Cancer. https://doi.org/10.1186/s12943-022-01499-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.